Showing results (11-20 of 191) with videos related to
Sort By:
Pageof 20
Oncotargets and Therapy|December 28, 2018
Ceritinib for an anaplastic lymphoma kinase rearrangement-positive patient previously treated with alectinib with poor performance statusRui Kitadai, Yusuke Okuma, Shoko KawaiLung Cancer (Amsterdam, Netherlands)|August 28, 2016
Immune-related pancreatitis secondary to nivolumab in a patient with recurrent lung adenocarcinoma: A case reportKazuhiko Ikeuchi, Yusuke Okuma, Taku TabataOncotargets and Therapy|October 28, 2016
A patient previously treated with ALK inhibitors for central nervous system lesions from ALK rearranged lung cancer: a case reportJumpei Kashima, Yusuke Okuma, Tsunekazu HishimaAdvanced Drug Delivery Reviews|June 1, 2023
Targeting microbiome, drug metabolism, and drug delivery in oncologyAi Sumiyoshi, Hiroyuki Fujii, Yusuke OkumaBMC Cancer|March 21, 2018
Re-challenging immune checkpoint inhibitor in a patient with advanced non-small cell lung cancer: a case reportTaiki Hakozaki, Yusuke Okuma, Jumpei KashimaCancers|May 1, 2019
Molecular and Morphological Profiling of Lung Cancer: A Foundation for "Next-Generation" Pathologists and OncologistsJumpei Kashima, Rui Kitadai, Yusuke OkumaOncotargets and Therapy|February 14, 2015
Lung cancer patients harboring epidermal growth factor receptor mutation among those infected by human immunodeficiency virusYusuke Okuma, Yukio Hosomi, Akifumi ImamuraOncology Letters|March 12, 2019
Impact of prior antibiotic use on the efficacy of nivolumab for non-small cell lung cancerTaiki Hakozaki, Yusuke Okuma, Miwako Omori, et al.Journal of Cancer Research and Clinical Oncology|December 13, 2019
The efficacy of immune checkpoint inhibitors in advanced non-small-cell lung cancer with liver metastasesRui Kitadai, Yusuke Okuma, Taiki Hakozaki, et al.Oncology Letters|October 9, 2014
Clinical outcome of thymic lymphoepithelioma-like carcinoma: Case report of a 14-year-old maleKuniko Sekihara, Yusuke Okuma, Hiroshi Kawamoto, et al.Pageof 20